-
Healthcare Cost and Resource Utilization among First Line (1L) Treated Patients with Metastatic Non-small Cell Lung Cancer (mNSCLC): Analysis of SEER-Medicare Linked Claims in the US
Mar 10, 2025, 14:00 PM -
Budget Impact Analysis of Continuous Glucose Monitoring with Predictive Alarms for Type 1 Diabetes in Chile (T1D): Perspective of the Explicit Health Guarantees Regime.
Mar 10, 2025, 14:00 PM -
Shades of Blue: Investigating Racial, Socioeconomic, and Family Dynamics in Depression Among Teen Girls
Mar 10, 2025, 14:00 PM -
A Case-Study on the Implementation of the Population Health Agreement for Inclisiran in England
Mar 10, 2025, 14:00 PM -
Cost Opportunity of Polatuzumab Vedotin as First-Line Therapy for DLBCL on Subsequent Treatments - Brazilian Cost Analysis
Mar 10, 2025, 14:00 PM -
Impact of Treatment Response on Quality of Life and Health-Related Utility Values in Hepatitis: A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Trends in Indirect Treatment Comparison (ITC) Methods Used in Reimbursement Submissions in Canada and the US
Mar 10, 2025, 14:00 PM -
Spillover Effects of Medical Innovations: A Generic and Scalable Approach to Measure the Societal Value of Avoided Informal Care Time
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Baricitinib Compared to Standard of Care in Improving Symptoms of Alopecia Areata for the Patients in the U.S. From the Healthcare Payer Perspective
Mar 10, 2025, 14:00 PM -
Evaluation of the Impact of Fezolinetant vs Placebo on Indirect Costs Among Women With VMS Associated With Menopause
Mar 10, 2025, 14:00 PM -
Discontinuation of Disease-Modifying Therapies in Older Adults with Multiple Sclerosis
Mar 10, 2025, 14:00 PM -
Trends in Respiratory Pathogen Testing With Individual Pathogen, Small Panel, or Large Panel Polymerase Chain Reaction (PCR) Tests Before and After the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (PHE) Ended
Mar 10, 2025, 14:00 PM -
Comparison of Generative AI and Manual Data Programming in a Lupus Health Productivity Loss Study
Mar 10, 2025, 14:00 PM -
Target Aggregate Data Adjustment Method (TADA): A Solution for Performing Transportability Analysis with Only Aggregate-Level Data in the Target Population
Mar 10, 2025, 14:00 PM -
Health Equity and Robotic-Assisted Surgery with the da Vinci Surgical Systems: A Literature Review
Mar 10, 2025, 14:00 PM -
A Systematic Review and Meta-Analysis of da Vinci Robotic-Assisted Surgery vs. Laparoscopic or Open Approaches for Benign Colon Conditions
Mar 10, 2025, 14:00 PM -
Large Language Model and Contextual Prioritization of Titles and Abstracts for Systematic Review Screening
Mar 10, 2025, 14:00 PM -
Economic Evaluation of Adjuvant Chemotherapy for Soft Tissue Sarcoma Using Linked NETSARC+ (French Registry) and SNDS (French National Health Data System) Real World Data: The Deepsarc Study
Mar 10, 2025, 14:00 PM -
Collaborations Between Pharma and Digital Health Startups: Advancing Innovation and Reimbursement in Digital Health Technologies
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Tolvaptan Vs. Angiotensin-Converting Enzyme Inhibitors for US Patients with Autosomal Dominant Polycystic Kidney Disease
Mar 10, 2025, 14:00 PM
